☆ 4.5 Letter

High exposure to erlotinib and severe drug-induced interstitial lung disease in patients with non-small-cell lung cancer

LUNG CANCER (2014)

Journal

LUNG CANCER

Volume 86, Issue 1, Pages 113-114

Publisher

ELSEVIER IRELAND LTD

DOI: 10.1016/j.lungcan.2014.07.021

Keywords

Erlotinib; Interstitial lung disease; Pharmacokinetics; High exposure; ABCG2; Polymorphism

Categories

Oncology Respiratory System

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.